CABANE A SUCRE BELLAVANCEBusiness Directories,Company Directories

Company Name: Corporate Name:	CABANE A SUCRE BELLAVANCE
Company Title:
Company Description:
Keywords to Search:
Company Address:	733 Rte Bellavance,SAINTE-CECILE-DE-WHITTON,QC,Canada
ZIP Code: Postal Code:	G0Y1J0
Telephone Number:	8195830441
Fax Number:	8195830441
Website:
Email:
USA SIC Code(Standard Industrial Classification Code):	083101
USA SIC Description:	Maple Sugar & Syrup
Number of Employees:	10 to 19
Sales Amount:	$2.5 to 5 million
Credit History: Credit Report:	Very Good
Contact Person:	France Bellavance
Remove my name

Company Directories & Business Directories

copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)

Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Previous company profile:
CONFECTION IDEALE INC
CLUB DE LAGE DOR
CAISSE POPULAIRE STE-CECILE

Next company profile:
STE-CHRISTINE MUNICIPALITE
SOCIETE CAN DES POSTES
SCIE RAY-DY BM

Company News:

Syneos Health (SYNH) Announces a $7. 1 Billion Merger Agreement
Syneos Health (SYNH) is set to become private company following a $7 1 billion merger deal to be acquired by a private investment consortium
Syneos Health (SYNH) Tops Q1 Earnings, Announces Merger Plan
Syneos Health's (SYNH) first-quarter 2023 earnings and revenues beat estimates The company enters into a definitive merger agreement to be acquired by a private investment consortium
Syneos Health (SYNH) to Go Private, Reports Q2 Performance
Syneos Health (SYNH) announces shareholders' approval for the impending merger and releases second-quarter 2023 financial results
Is Syneos Health (SYNH) a Good Value Investor Stock Now?
Let's see if Syneos Health (SYNH) stock is a good choice for value-oriented investors right now from multiple angles
Syneos Health (SYNH) Sell-Off Appears Strategic Amid Margin Woes
Syneos Health's (SYNH) purchase price represents a 24% premium to its unaffected closing stock price prior to the announcement Margin pressure continues to weigh on the stock
Syneos Health to be Acquired by a Private Investment Consortium for . . .
Shareholders to Receive $43 00 Per Share in Cash Represents 24% Premium to Unaffected Stock Price MORRISVILLE, N C , May 10, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc (Nasdaq: SYNH) (“Syneos
Syneos Health Inc (SYNH) CFO Jason M. Meggs Sold $504,000 of Shares
CFO of Syneos Health Inc (30-Year Financial, Insider Trades) Jason M Meggs (insider trades) sold 6,000 shares of SYNH on 04 15 2021 at an average price of $84 a share
Syneos Health (SYNH) Down 0. 1% Since Last Earnings Report: Can It Rebound?
Syneos Health (SYNH) reported earnings 30 days ago What's next for the stock? We take a look at earnings estimates for some clues
Heres Why Investors Should Retain Syneos Health (SYNH) for Now
Syneos Health's (SYNH) share price movement is expected to be favorable due to the strength of the company's Syneos One portfolio and several value-added partnership deals
Is SYNH Stock A Buy or Sell? - Yahoo Finance
Is SYNH stock a buy? Prominent investors were in a bearish mood The number of bullish hedge fund positions retreated by 11 in recent months